CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.50
+0.03 (0.55%)
At close: Aug 13, 2025, 4:00 PM
5.46
-0.04 (-0.73%)
Pre-market: Aug 14, 2025, 9:04 AM EDT
CureVac Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for CureVac stock ranges from a low of $5.00 to a high of $10. The average analyst price target of $6.83 forecasts a 24.18% increase in the stock price over the next year.
Price Target: $6.83 (+24.18%)
Analyst Consensus: Hold
* Price targets were last updated on Jun 26, 2025.
Analyst Ratings
The average analyst rating for CureVac stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 0 | 0 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades $12 → $5.5 | Strong Buy → Hold | Downgrades | $12 → $5.5 | n/a | Jun 26, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $7 → $5 | Strong Buy → Hold | Downgrades | $7 → $5 | -9.09% | Jun 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $10 | Buy | Reiterates | $10 | +81.82% | May 28, 2025 |
| UBS | UBS | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +118.18% | Apr 30, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +190.91% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
70.41M
from 535.18M
Decreased by -86.84%
Revenue Next Year
87.33M
from 70.41M
Increased by 24.04%
EPS This Year
-0.48
from 0.72
EPS Next Year
-0.46
from -0.48
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 133.6M | 166.5M | 224.2M | ||
| Avg | 70.4M | 87.3M | 139.7M | ||
| Low | 882,000 | n/a | 78.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -75.0% | 136.4% | 156.7% | ||
| Avg | -86.8% | 24.0% | 59.9% | ||
| Low | -99.8% | - | -9.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.13 | -0.16 | 0.33 |
| Avg | -0.48 | -0.46 | -0.20 |
| Low | -0.73 | -0.77 | -0.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.